Project Grant HT94252510947
Award Date 11/1/25
Completion Date 10/31/27
Dollars Obligated $176K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
- The Defense Health Agency awarded a $619,500 Project Grant to the Sloan-Kettering Institute for Cancer Research, a non-profit organization in New York, NY. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program and will support research to investigate the immunogenicity and targeting of shared neoantigens in adenoid cystic cancer over a 3-year period from September 1, 2023 to August 31, 2026. The research aims to transform health care for Service...
- The Sloan-Kettering Institute for Cancer Research received a $1,626,500 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on September 15, 2025. The award, with a performance period running through September 14, 2029, supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The Sloan-Kettering Institute, a leading nonprofit cancer research institution, will leverage the...
- The Sloan-Kettering Institute for Cancer Research was awarded a $707,346 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2024, supports Sloan-Kettering's cancer research initiatives, including investigations into the tumor microenvironment, mechanisms of metastasis, epigenetic alterations in cancer, resistance to cancer therapies, aging-related biology, and hematologic malignancies....
- Sloan-Kettering Institute For Cancer Research was awarded a $796,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of July 15, 2023 through July 14, 2026. The grant will support research to develop novel tools to improve responses to DNA-damaging therapeutics in metastatic breast cancer. As the prime recipient, Sloan-Kettering Institute For Cancer Research will leverage its expertise in cancer biology,...
- The U.S. Defense Health Agency awarded a $176,000 Project Grant to the Sloan-Kettering Institute for Cancer Research to establish a mouse model of myxoid/round cell liposarcoma with endogenous translocations. This research falls under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical investigations to transform healthcare for military service members, veterans, and the broader public. The project will be conducted from September 1, 2025...
- The federal Project Grant award of $1,108,654.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by the Sloan-Kettering Institute for Cancer Research to accelerate global research for relapsed or refractory extracranial malignant germ cell tumors. The award, effective from September 30, 2025 to September 29, 2029, will enable the institute to conduct comprehensive cancer-related services, including research,...
- The Sloan-Kettering Institute for Cancer Research was awarded a $1,295,691 Project Grant on November 1, 2024 under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The funding will support research aimed at "Targeting Hypermethylation to Overcome Cisplatin Resistance in Patients with Relapsed/Refractory Germ Cell Tumors" over a performance period ending on October 31, 2027. As a leading comprehensive cancer...
- This $664,456 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research. The award will fund a 3-year research project focused on investigating biomarkers of immune response in mismatch repair-deficient (MMR-D) endometrial cancer treated with immune checkpoint blockade and radiation. The research aims to advance the understanding of cancer immunology and develop new...
- The Defense Health Agency awarded a $924,000 Project Grant to the Sloan-Kettering Institute for Cancer Research in New York, NY under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2025, supports research to develop "Therapeutic Strategies for Targeting Diverse KRAS Mutations in Lung Cancer" with a performance period through May 31, 2028. The Sloan-Kettering Institute, a leading comprehensive cancer center, will conduct advanced...
- This federal Project Grant award of $352,000.00, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the Sloan-Kettering Institute for Cancer Research to augment the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma. The research project aims to investigate innovative approaches to enhance the therapeutic potential of this novel compound for treating glioblastoma, an aggressive...